9^th Swiss-Scandinavian Bio-Business Seminar

February 5, 2015 at SIX Stock Exchange building in Zurich.

REGISTRATION IS NOW CLOSED DUE TO MAXIMUM NUMBER OF PARTICIPANTS REACHED

The 9^th Swiss-Scandinavian Bio-Business Seminar is organized by the Nordic countries in cooperation with Swiss partners. During this high-level partnering and investor conference, Swiss and Nordic biotech and pharmaceutical companies as well as investors meet in one-to-one meetings and present themselves in plenum.

The goal of the conference and by means of the Swiss-Nordic focus is to establish new contacts and networks.

• The previous SSBBS 2014 gathered more than 120 participants.
• A record of over 270 one-to-one meetings took place.
• In nearly 50% of the matchmaking meetings, further contact was planned or a cooperation considered 
  
  Confirmed participants include:

• MS Ventures  – Seventure Partner  – Bay City Capital  – Roche Venture Fund  – Novartis Venture Fund – Sunstone Capital –Creathor Venture – Novo Seeds – Aravis  – Endeavour Vision  – Redalpine  – Agire Invest  – Index Ventures – Industrifonden  – HBM Partners – Sarsia Seeds – NeoMed Management

• Roche  – Novartis  – Pfizer – Takeda – MSD  – Roche Diagnostics  – Tillotts Pharma  – Vifor Pharma  –  Alexion Pharma
  
  

FOR MORE INFO go to "About SSBBS". 

Organisers

In cooperation with

Supported by